Delivery Order SPE2DB25D3306-SPE2DB25FUBCY
Award Date 3/18/25
Potential Completion Date 3/19/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,030.88 firm fixed-price delivery order is for the supply of Hysingla ER 20 mg tablets, a medication used for pain management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,030.71, is a delivery order for HYSINGLA ER TABS 40MG, a type of extended-release hydrocodone medication. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYSINGLA ER 20 MG TABLET 60S. The contract has a firm fixed price of $2,730.98 and an ultimate completion date of August 27, 2024. It is not a set-aside contract. Amerisourcebergen, through its Corporate Office division, has extensive experience providing a wide range of pharmaceutical products and medical supplies to support various federal...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDXY7, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,105.69, is for the delivery of HYSINGLA ER 40 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 7, 2025 and was awarded on February 6, 2025. It is a Firm Fixed Price contract with no...
- This federal contract award, valued at $7,177.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hysingla ER 30 mg tablets, a medication used for pain management. This contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $8,504.08 to AmerisourceBergen Drug Corp for the supply of Hysingla ER 20 mg tablets (60-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 80 mg Hysingla ER tablets, with a ceiling value of $1,531.57. The contract, which is not set-aside and employs firm fixed-price terms, was awarded on December 31, 2025, with an ultimate completion date of January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Hysingla ER 30 mg tablets (60-count packages) with a ceiling value of $1,915.14. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for completion by January 6, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Hysingla ER...
- On January 14, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,709.86 to AmerisourceBergen Drug Corp for the supply of Hysingla ER 40 mg tablets (60-count package). This non-set-aside, firm fixed-price contract is scheduled for completion by January 15, 2026, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- This federal contract award is for the delivery of 12mg hydromorphone hydrochloride extended-release tablets to the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The $10,039.59 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 12, 2025, with a completion date of May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...